Xpert Hepatitis-C Virus (HCV) Test on the GeneXpert Xpress System
NCT ID: NCT06508996
Last Updated: 2024-07-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1012 participants
OBSERVATIONAL
2024-02-06
2024-06-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Use of the GenXpert to Detect Hepatitis C RNA
NCT04717856
Hepatitis C: Community Testing and Treatment (CT2 Study Myanmar)
NCT03939013
Observational Study of the Interaction Between Hepatitis C Virus Infection and Pregnancy
NCT05929963
PoC-HCV Genedrive Viral Detection Assay Validation Study
NCT02992184
Hepatitis C Lab Testing Comparison Study
NCT06380166
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Capillary whole blood
Capillary whole blood from individuals with signs and symptoms and/or at-risk of HCV infection
Xpert HCV
Detection of HCV RNA by Xpert HCV test
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Xpert HCV
Detection of HCV RNA by Xpert HCV test
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participant was not on treatment at time of enrollment based on review of medical records or self-reported
* Participant had signs and symptoms and/or is considered at-risk of HCV infection
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Emory University
OTHER
Cepheid
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer Havens
Role: PRINCIPAL_INVESTIGATOR
University of Kentucky College of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Kentucky
Lexington, Kentucky, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
293C
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.